EBV-Driven CD4+ T Cells Link Epstein-Barr Virus to MS, Opening Immunotherapy Avenues

TL;DR Summary
New research shows Epstein–Barr virus activates CD4+ T cells that attack nerve insulation in multiple sclerosis, and that anti-CD20 therapies (which reduce B cells and viral stimuli) lower CD4+ T-cell responses and EBV activity—hinting immunotherapies could slow relapses and progression.
Topics:health#anti-cd20-therapy#cd4-t-cells#epstein-barr-virus#frexalimab#multiple-sclerosis#science
- Biologists pinpoint how common virus triggers multiple sclerosis Nature
- From ‘kissing disease’ to MS: Harvard study uncovers how a common virus triggers multiple sclerosis The Boston Globe
- Best treatment for multiple sclerosis may be antivirals New Scientist
- New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosis STAT
- Epstein-Barr virus components linked to the development of multiple sclerosis have been identified Science Media Centre España
Reading Insights
Total Reads
1
Unique Readers
2
Time Saved
6 min
vs 7 min read
Condensed
97%
1,265 → 40 words
Want the full story? Read the original article
Read on Nature